Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Abbisko Therapeutics Co, Ltd

Clinical trials sponsored by Abbisko Therapeutics Co, Ltd, explained in plain language.

Trials to join now! 6 Not yet recruiting 2 Not yet finished but already full! 3 Completed 2

New drug combo targets tough lung cancer mutation

Disease control Not yet recruiting

This study tests two experimental drugs (ABSK043 and glecirasib) together in people with advanced non-small cell lung cancer that has a specific KRAS G12C mutation. The goal is to see if the combination is safe and shrinks tumors. About 86 adults will take part in this open-label…

Phase: PHASE2 • Sponsor: Abbisko Therapeutics Co, Ltd • Aim: Disease control

Last updated May 26, 2026 11:46 UTC
New drug aims to boost growth in kids with dwarfism

Disease control Not yet recruiting

This study tests a new medicine called ABSK061 in 110 children with achondroplasia (a common form of dwarfism). The goal is to see if it is safe and can help children grow taller. The study is open-label, meaning everyone knows they are getting the drug, and it will last for at l…

Phase: PHASE1, PHASE2 • Sponsor: Abbisko Therapeutics Co, Ltd • Aim: Disease control

Last updated May 18, 2026 12:01 UTC